+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID07581951

Evaluating the Safety and Effects of HSK31679 in Adults With Metabolic Dysfunction-Associated Steatohepatitis MASH in a Randomized, Placebo-Controlled Study

Led by Haisco Pharmaceutical Group Co., Ltd. · Updated on 2026-09-23

886

Participants Needed

1

Research Sites

182 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effects of the drug HSK31679 in adults with metabolic dysfunction-associated steatohepatitis MASH, a serious liver condition. This phase 3, randomized, double-blind, placebo-controlled study aims to compare HSK31679 to a placebo to better understand its impact on MASH and liver fibrosis. The study consists of two parts based on specific liver biopsy or non-invasive test criteria to assess both the drugs effect and safety in improving liver function. Participants will receive either an oral tablet of HSK31679 once daily or a matching placebo. The first part focuses on evaluating how HSK31679 affects MASH and liver fibrosis, while the second part aims to determine its safety in improving liver health. Treatments are assigned randomly, and neither participants nor researchers know who receives the drug or placebo to maintain impartial results. During the study, participants will undergo screening including liver biopsies or non-invasive tests to confirm eligibility. Researchers will monitor liver health and fibrosis stages over time, with key measurements at 52 weeks and up to 4.5 years for disease progression. Safety and tolerability are closely observed, ensuring participant health throughout the study period, which can last several years from enrollment to completion.

CONDITIONS

Brief Title

A Phase 3 Study Evaluating the Safety and Efficacy of HSK31679 in Patients With MASH

Research Team

F

fangqiong li

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here